nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—Ovarian cancer—Docetaxel—head and neck cancer	0.0383	0.0724	CcSEcCtD
Raloxifene—Thromboembolic event—Docetaxel—head and neck cancer	0.0247	0.0467	CcSEcCtD
Raloxifene—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.0218	0.0411	CcSEcCtD
Raloxifene—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.0157	0.0296	CcSEcCtD
Raloxifene—Tenderness—Hydroxyurea—head and neck cancer	0.0147	0.0277	CcSEcCtD
Raloxifene—Deep vein thrombosis—Docetaxel—head and neck cancer	0.0109	0.0207	CcSEcCtD
Raloxifene—Tenderness—Fluorouracil—head and neck cancer	0.0106	0.02	CcSEcCtD
Raloxifene—Cerebrovascular accident—Vinblastine—head and neck cancer	0.0104	0.0196	CcSEcCtD
Raloxifene—Embolism—Docetaxel—head and neck cancer	0.0104	0.0196	CcSEcCtD
Raloxifene—Neuralgia—Docetaxel—head and neck cancer	0.00957	0.0181	CcSEcCtD
Raloxifene—Breast disorder—Hydroxyurea—head and neck cancer	0.0084	0.0159	CcSEcCtD
Raloxifene—Depression—Vinblastine—head and neck cancer	0.00783	0.0148	CcSEcCtD
Raloxifene—Weight increased—Hydroxyurea—head and neck cancer	0.00731	0.0138	CcSEcCtD
Raloxifene—Hypoaesthesia—Vinblastine—head and neck cancer	0.00701	0.0133	CcSEcCtD
Raloxifene—Pharyngitis—Vinblastine—head and neck cancer	0.007	0.0132	CcSEcCtD
Raloxifene—Pulmonary embolism—Docetaxel—head and neck cancer	0.00665	0.0126	CcSEcCtD
Raloxifene—Blood pressure increased—Docetaxel—head and neck cancer	0.00665	0.0126	CcSEcCtD
Raloxifene—Angiopathy—Hydroxyurea—head and neck cancer	0.00583	0.011	CcSEcCtD
Raloxifene—Vertigo—Vinblastine—head and neck cancer	0.00551	0.0104	CcSEcCtD
Raloxifene—Pneumonia—Fluorouracil—head and neck cancer	0.00518	0.0098	CcSEcCtD
Raloxifene—Hot flush—Docetaxel—head and neck cancer	0.00516	0.00975	CcSEcCtD
Raloxifene—Menopausal symptoms—Docetaxel—head and neck cancer	0.00512	0.00967	CcSEcCtD
Raloxifene—Urinary tract infection—Fluorouracil—head and neck cancer	0.00501	0.00947	CcSEcCtD
Raloxifene—Conjunctivitis—Fluorouracil—head and neck cancer	0.00501	0.00947	CcSEcCtD
Raloxifene—Thrombocytopenia—Vinblastine—head and neck cancer	0.0049	0.00926	CcSEcCtD
Raloxifene—Sinusitis—Fluorouracil—head and neck cancer	0.00484	0.00914	CcSEcCtD
Raloxifene—Migraine—Docetaxel—head and neck cancer	0.00475	0.00898	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00473	0.00894	CcSEcCtD
Raloxifene—Rhinitis—Fluorouracil—head and neck cancer	0.00464	0.00877	CcSEcCtD
Raloxifene—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0046	0.0087	CcSEcCtD
Raloxifene—Pharyngitis—Fluorouracil—head and neck cancer	0.00459	0.00868	CcSEcCtD
Raloxifene—Infection—Hydroxyurea—head and neck cancer	0.00454	0.00857	CcSEcCtD
Raloxifene—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00448	0.00846	CcSEcCtD
Raloxifene—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00447	0.00845	CcSEcCtD
Raloxifene—Skin disorder—Hydroxyurea—head and neck cancer	0.00444	0.00838	CcSEcCtD
Raloxifene—Breast disorder—Docetaxel—head and neck cancer	0.00436	0.00824	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00435	0.00821	CcSEcCtD
Raloxifene—Pain—Vinblastine—head and neck cancer	0.00428	0.00809	CcSEcCtD
Raloxifene—Gastrointestinal pain—Vinblastine—head and neck cancer	0.0041	0.00774	CcSEcCtD
Raloxifene—Dyspepsia—Hydroxyurea—head and neck cancer	0.00402	0.0076	CcSEcCtD
Raloxifene—Abdominal pain—Vinblastine—head and neck cancer	0.00396	0.00748	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00394	0.00745	CcSEcCtD
Raloxifene—Pain—Hydroxyurea—head and neck cancer	0.00391	0.00738	CcSEcCtD
Raloxifene—Weight increased—Docetaxel—head and neck cancer	0.0038	0.00717	CcSEcCtD
Raloxifene—Pneumonia—Docetaxel—head and neck cancer	0.00374	0.00707	CcSEcCtD
Raloxifene—Conjunctivitis—Docetaxel—head and neck cancer	0.00362	0.00683	CcSEcCtD
Raloxifene—Body temperature increased—Hydroxyurea—head and neck cancer	0.00361	0.00682	CcSEcCtD
Raloxifene—Chest pain—Fluorouracil—head and neck cancer	0.00343	0.00648	CcSEcCtD
Raloxifene—Myalgia—Fluorouracil—head and neck cancer	0.00343	0.00648	CcSEcCtD
Raloxifene—Diarrhoea—Vinblastine—head and neck cancer	0.00343	0.00647	CcSEcCtD
Raloxifene—Rhinitis—Docetaxel—head and neck cancer	0.00335	0.00633	CcSEcCtD
Raloxifene—Hypoaesthesia—Docetaxel—head and neck cancer	0.00332	0.00628	CcSEcCtD
Raloxifene—Pharyngitis—Docetaxel—head and neck cancer	0.00331	0.00626	CcSEcCtD
Raloxifene—Dizziness—Vinblastine—head and neck cancer	0.00331	0.00626	CcSEcCtD
Raloxifene—Urinary tract disorder—Docetaxel—head and neck cancer	0.0033	0.00623	CcSEcCtD
Raloxifene—Oedema peripheral—Docetaxel—head and neck cancer	0.00329	0.00622	CcSEcCtD
Raloxifene—Connective tissue disorder—Docetaxel—head and neck cancer	0.00328	0.0062	CcSEcCtD
Raloxifene—Urethral disorder—Docetaxel—head and neck cancer	0.00327	0.00619	CcSEcCtD
Raloxifene—Infection—Fluorouracil—head and neck cancer	0.00327	0.00617	CcSEcCtD
Raloxifene—Nervous system disorder—Fluorouracil—head and neck cancer	0.00322	0.00609	CcSEcCtD
Raloxifene—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00322	0.00608	CcSEcCtD
Raloxifene—Vomiting—Vinblastine—head and neck cancer	0.00318	0.00602	CcSEcCtD
Raloxifene—Headache—Vinblastine—head and neck cancer	0.00314	0.00593	CcSEcCtD
Raloxifene—Diarrhoea—Hydroxyurea—head and neck cancer	0.00313	0.0059	CcSEcCtD
Raloxifene—Cardiac disorder—Docetaxel—head and neck cancer	0.0031	0.00586	CcSEcCtD
Raloxifene—Flushing—Docetaxel—head and neck cancer	0.0031	0.00586	CcSEcCtD
Raloxifene—Angiopathy—Docetaxel—head and neck cancer	0.00303	0.00573	CcSEcCtD
Raloxifene—Dizziness—Hydroxyurea—head and neck cancer	0.00302	0.00571	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.003	0.00566	CcSEcCtD
Raloxifene—Nausea—Vinblastine—head and neck cancer	0.00297	0.00562	CcSEcCtD
Raloxifene—Insomnia—Fluorouracil—head and neck cancer	0.00297	0.00562	CcSEcCtD
Raloxifene—Vomiting—Hydroxyurea—head and neck cancer	0.0029	0.00549	CcSEcCtD
Raloxifene—Dyspepsia—Fluorouracil—head and neck cancer	0.00289	0.00547	CcSEcCtD
Raloxifene—Rash—Hydroxyurea—head and neck cancer	0.00288	0.00544	CcSEcCtD
Raloxifene—Dermatitis—Hydroxyurea—head and neck cancer	0.00288	0.00544	CcSEcCtD
Raloxifene—Headache—Hydroxyurea—head and neck cancer	0.00286	0.00541	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00284	0.00536	CcSEcCtD
Raloxifene—Pain—Fluorouracil—head and neck cancer	0.00281	0.00531	CcSEcCtD
Raloxifene—Muscle spasms—Docetaxel—head and neck cancer	0.0028	0.00528	CcSEcCtD
Raloxifene—Nausea—Hydroxyurea—head and neck cancer	0.00271	0.00513	CcSEcCtD
Raloxifene—Syncope—Docetaxel—head and neck cancer	0.00261	0.00493	CcSEcCtD
Raloxifene—Body temperature increased—Fluorouracil—head and neck cancer	0.0026	0.00491	CcSEcCtD
Raloxifene—Loss of consciousness—Docetaxel—head and neck cancer	0.00256	0.00483	CcSEcCtD
Raloxifene—Cough—Docetaxel—head and neck cancer	0.00254	0.00479	CcSEcCtD
Raloxifene—Chest pain—Docetaxel—head and neck cancer	0.00248	0.00468	CcSEcCtD
Raloxifene—Myalgia—Docetaxel—head and neck cancer	0.00248	0.00468	CcSEcCtD
Raloxifene—Arthralgia—Docetaxel—head and neck cancer	0.00248	0.00468	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00246	0.00464	CcSEcCtD
Raloxifene—Infection—Docetaxel—head and neck cancer	0.00236	0.00445	CcSEcCtD
Raloxifene—Shock—Docetaxel—head and neck cancer	0.00233	0.00441	CcSEcCtD
Raloxifene—Nervous system disorder—Docetaxel—head and neck cancer	0.00233	0.0044	CcSEcCtD
Raloxifene—Thrombocytopenia—Docetaxel—head and neck cancer	0.00232	0.00439	CcSEcCtD
Raloxifene—Skin disorder—Docetaxel—head and neck cancer	0.0023	0.00435	CcSEcCtD
Raloxifene—Diarrhoea—Fluorouracil—head and neck cancer	0.00225	0.00425	CcSEcCtD
Raloxifene—Dizziness—Fluorouracil—head and neck cancer	0.00217	0.00411	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00216	0.00408	CcSEcCtD
Raloxifene—Insomnia—Docetaxel—head and neck cancer	0.00215	0.00405	CcSEcCtD
Raloxifene—Vomiting—Fluorouracil—head and neck cancer	0.00209	0.00395	CcSEcCtD
Raloxifene—Dyspepsia—Docetaxel—head and neck cancer	0.00209	0.00395	CcSEcCtD
Raloxifene—Rash—Fluorouracil—head and neck cancer	0.00207	0.00392	CcSEcCtD
Raloxifene—Dermatitis—Fluorouracil—head and neck cancer	0.00207	0.00391	CcSEcCtD
Raloxifene—Headache—Fluorouracil—head and neck cancer	0.00206	0.00389	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00205	0.00387	CcSEcCtD
Raloxifene—Pain—Docetaxel—head and neck cancer	0.00203	0.00383	CcSEcCtD
Raloxifene—Nausea—Fluorouracil—head and neck cancer	0.00195	0.00369	CcSEcCtD
Raloxifene—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00194	0.00367	CcSEcCtD
Raloxifene—Abdominal pain—Docetaxel—head and neck cancer	0.00188	0.00354	CcSEcCtD
Raloxifene—Body temperature increased—Docetaxel—head and neck cancer	0.00188	0.00354	CcSEcCtD
Raloxifene—Diarrhoea—Docetaxel—head and neck cancer	0.00162	0.00307	CcSEcCtD
Raloxifene—Dizziness—Docetaxel—head and neck cancer	0.00157	0.00296	CcSEcCtD
Raloxifene—Vomiting—Docetaxel—head and neck cancer	0.00151	0.00285	CcSEcCtD
Raloxifene—Rash—Docetaxel—head and neck cancer	0.0015	0.00283	CcSEcCtD
Raloxifene—Dermatitis—Docetaxel—head and neck cancer	0.00149	0.00282	CcSEcCtD
Raloxifene—Headache—Docetaxel—head and neck cancer	0.00149	0.00281	CcSEcCtD
Raloxifene—Nausea—Docetaxel—head and neck cancer	0.00141	0.00266	CcSEcCtD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000929	0.00197	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000928	0.00197	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—KISS1—head and neck cancer	0.000923	0.00196	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000918	0.00195	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—KISS1—head and neck cancer	0.000918	0.00195	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—NAT2—head and neck cancer	0.000906	0.00192	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000891	0.00189	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000891	0.00189	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—YAP1—head and neck cancer	0.00089	0.00189	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000883	0.00187	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000882	0.00187	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000875	0.00186	CbGpPWpGaD
Raloxifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000869	0.00185	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	0.000868	0.00184	CbGpPWpGaD
Raloxifene—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000857	0.00182	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000857	0.00182	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—KISS1—head and neck cancer	0.000838	0.00178	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	0.000834	0.00177	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000833	0.00177	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—GRP—head and neck cancer	0.000832	0.00177	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	0.000823	0.00175	CbGpPWpGaD
Raloxifene—EBP—Metabolism—TYMS—head and neck cancer	0.000816	0.00173	CbGpPWpGaD
Raloxifene—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000812	0.00172	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GSTM1—head and neck cancer	0.000807	0.00171	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000799	0.0017	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000797	0.00169	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—DPYD—head and neck cancer	0.000794	0.00169	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000788	0.00167	CbGpPWpGaD
Raloxifene—EBP—Metabolism—GPX1—head and neck cancer	0.000773	0.00164	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.00077	0.00164	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000766	0.00163	CbGpPWpGaD
Raloxifene—EBP—Metabolism—CYP1A1—head and neck cancer	0.000765	0.00163	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000764	0.00162	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—GRP—head and neck cancer	0.00076	0.00161	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—GRP—head and neck cancer	0.000756	0.00161	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	0.000755	0.0016	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—YAP1—head and neck cancer	0.000753	0.0016	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000741	0.00157	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000738	0.00157	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000735	0.00156	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000725	0.00154	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—UROD—head and neck cancer	0.000724	0.00154	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	0.000721	0.00153	CbGpPWpGaD
Raloxifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000704	0.0015	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.000697	0.00148	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—GRP—head and neck cancer	0.00069	0.00147	CbGpPWpGaD
Raloxifene—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000687	0.00146	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000684	0.00145	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000666	0.00142	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	0.000666	0.00142	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000661	0.0014	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000661	0.0014	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	0.000657	0.0014	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000629	0.00134	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000628	0.00133	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000627	0.00133	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000626	0.00133	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—UROD—head and neck cancer	0.000613	0.0013	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.0006	0.00127	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.0006	0.00127	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000597	0.00127	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000567	0.0012	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	0.000561	0.00119	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000547	0.00116	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KISS1—head and neck cancer	0.000542	0.00115	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000537	0.00114	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000537	0.00114	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	0.000534	0.00113	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	0.000534	0.00113	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000511	0.00108	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000504	0.00107	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000497	0.00106	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KISS1—head and neck cancer	0.000495	0.00105	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000494	0.00105	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—RARB—head and neck cancer	0.000493	0.00105	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000492	0.00105	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000486	0.00103	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000486	0.00103	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000476	0.00101	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000471	0.001	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NAT2—head and neck cancer	0.000468	0.000995	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000468	0.000994	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000464	0.000985	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PTGS2—head and neck cancer	0.000455	0.000967	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—TYMS—head and neck cancer	0.000452	0.000961	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000451	0.000958	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—YAP1—head and neck cancer	0.000449	0.000953	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GSTM1—head and neck cancer	0.000447	0.00095	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GRP—head and neck cancer	0.000446	0.000948	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000445	0.000945	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000445	0.000945	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—STAT6—head and neck cancer	0.000433	0.000921	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	0.000429	0.000911	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GPX1—head and neck cancer	0.000428	0.00091	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000425	0.000903	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CYP1A1—head and neck cancer	0.000424	0.000901	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000422	0.000896	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.00042	0.000892	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KISS1—head and neck cancer	0.000412	0.000876	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—DPYD—head and neck cancer	0.000411	0.000872	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GRP—head and neck cancer	0.000408	0.000866	CbGpPWpGaD
Raloxifene—AOX1—Disease—NOTCH1—head and neck cancer	0.000405	0.000861	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—NOTCH1—head and neck cancer	0.000401	0.000852	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PTEN—head and neck cancer	0.000397	0.000843	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—STAT6—head and neck cancer	0.000396	0.00084	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000395	0.000838	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00039	0.000829	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—YAP1—head and neck cancer	0.00039	0.000828	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000389	0.000827	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000386	0.00082	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—YAP1—head and neck cancer	0.000384	0.000815	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000381	0.000809	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	0.000379	0.000804	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000374	0.000795	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000374	0.000794	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000369	0.000784	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—YAP1—head and neck cancer	0.00035	0.000744	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GRP—head and neck cancer	0.000339	0.000721	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—STAT6—head and neck cancer	0.00033	0.0007	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—UROD—head and neck cancer	0.000329	0.000699	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000315	0.00067	CbGpPWpGaD
Raloxifene—AOX1—Disease—PTGS2—head and neck cancer	0.000301	0.00064	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NAT2—head and neck cancer	0.000301	0.000639	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000293	0.000622	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—YAP1—head and neck cancer	0.000292	0.00062	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PIK3CA—head and neck cancer	0.00028	0.000595	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00027	0.000574	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000268	0.000569	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—DPYD—head and neck cancer	0.000264	0.00056	CbGpPWpGaD
Raloxifene—AOX1—Disease—PTEN—head and neck cancer	0.000263	0.000558	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000255	0.000542	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NAT2—head and neck cancer	0.000255	0.000541	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTGS2—head and neck cancer	0.000252	0.000536	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—YAP1—head and neck cancer	0.00025	0.000532	CbGpPWpGaD
Raloxifene—AOX1—Disease—STAT3—head and neck cancer	0.000235	0.000499	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—TYMS—head and neck cancer	0.000234	0.000497	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTM1—head and neck cancer	0.000231	0.000491	CbGpPWpGaD
Raloxifene—EBP—Metabolism—AKT1—head and neck cancer	0.000229	0.000486	CbGpPWpGaD
Raloxifene—AOX1—Disease—MAPK3—head and neck cancer	0.000224	0.000477	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—DPYD—head and neck cancer	0.000223	0.000474	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MAPK3—head and neck cancer	0.000222	0.000471	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—IL2—head and neck cancer	0.000222	0.000471	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GPX1—head and neck cancer	0.000221	0.00047	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTEN—head and neck cancer	0.00022	0.000467	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP1A1—head and neck cancer	0.000219	0.000466	CbGpPWpGaD
Raloxifene—AOX1—Disease—MAPK1—head and neck cancer	0.000213	0.000453	CbGpPWpGaD
Raloxifene—AOX1—Disease—EGFR—head and neck cancer	0.000213	0.000453	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—YAP1—head and neck cancer	0.000212	0.00045	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—IL2—head and neck cancer	0.000202	0.00043	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NOTCH1—head and neck cancer	0.000202	0.00043	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL2—head and neck cancer	0.000201	0.000428	CbGpPWpGaD
Raloxifene—AOX1—Disease—PIK3CA—head and neck cancer	0.000185	0.000393	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL2—head and neck cancer	0.000184	0.000391	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.00018	0.000383	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOTCH1—head and neck cancer	0.000173	0.000367	CbGpPWpGaD
Raloxifene—AOX1—Disease—HRAS—head and neck cancer	0.000171	0.000364	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MAPK3—head and neck cancer	0.000162	0.000344	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000159	0.000338	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOTCH1—head and neck cancer	0.000158	0.000335	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PIK3CA—head and neck cancer	0.000155	0.00033	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MAPK1—head and neck cancer	0.000154	0.000327	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EGFR—head and neck cancer	0.000154	0.000327	CbGpPWpGaD
Raloxifene—AOX1—Disease—AKT1—head and neck cancer	0.000151	0.000321	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TYMS—head and neck cancer	0.00015	0.000319	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—AKT1—head and neck cancer	0.00015	0.000318	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTM1—head and neck cancer	0.000149	0.000316	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MAPK3—head and neck cancer	0.000148	0.000314	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000147	0.000313	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GPX1—head and neck cancer	0.000142	0.000302	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP1A1—head and neck cancer	0.000141	0.000299	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MAPK1—head and neck cancer	0.000141	0.000299	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EGFR—head and neck cancer	0.000141	0.000299	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000139	0.000295	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NAT2—head and neck cancer	0.000137	0.00029	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000134	0.000285	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PIK3CA—head and neck cancer	0.000134	0.000284	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	0.000131	0.000279	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTGS2—head and neck cancer	0.00013	0.000277	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TYMS—head and neck cancer	0.000127	0.00027	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—AKT1—head and neck cancer	0.000127	0.000269	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTM1—head and neck cancer	0.000126	0.000267	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HRAS—head and neck cancer	0.000124	0.000263	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PIK3CA—head and neck cancer	0.000122	0.000259	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GPX1—head and neck cancer	0.00012	0.000256	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—AKT1—head and neck cancer	0.00012	0.000255	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—DPYD—head and neck cancer	0.00012	0.000255	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP1A1—head and neck cancer	0.000119	0.000253	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL2—head and neck cancer	0.000119	0.000253	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCND1—head and neck cancer	0.000116	0.000246	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—YAP1—head and neck cancer	0.000114	0.000242	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTEN—head and neck cancer	0.000114	0.000242	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HRAS—head and neck cancer	0.000113	0.00024	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTEN—head and neck cancer	0.000112	0.000238	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MAPK3—head and neck cancer	0.000112	0.000238	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—AKT1—head and neck cancer	0.00011	0.000233	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—AKT1—head and neck cancer	0.000109	0.000232	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL2—head and neck cancer	0.000109	0.000231	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCND1—head and neck cancer	0.000106	0.000225	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTEN—head and neck cancer	0.000102	0.000217	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—head and neck cancer	0.000101	0.000215	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—STAT3—head and neck cancer	0.0001	0.000213	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—AKT1—head and neck cancer	9.97e-05	0.000212	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.79e-05	0.000208	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAPK3—head and neck cancer	9.56e-05	0.000203	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	9.23e-05	0.000196	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—STAT3—head and neck cancer	9.14e-05	0.000194	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAPK1—head and neck cancer	9.1e-05	0.000193	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EGFR—head and neck cancer	9.1e-05	0.000193	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL2—head and neck cancer	9.05e-05	0.000192	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCND1—head and neck cancer	8.82e-05	0.000187	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	8.73e-05	0.000185	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTEN—head and neck cancer	8.51e-05	0.000181	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTGS2—head and neck cancer	8.37e-05	0.000178	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	8.31e-05	0.000176	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EGFR—head and neck cancer	8.31e-05	0.000176	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CA—head and neck cancer	8.02e-05	0.00017	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CA—head and neck cancer	7.9e-05	0.000168	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—head and neck cancer	7.69e-05	0.000163	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—head and neck cancer	7.64e-05	0.000162	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—STAT3—head and neck cancer	7.61e-05	0.000162	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—AKT1—head and neck cancer	7.54e-05	0.00016	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HRAS—head and neck cancer	7.31e-05	0.000155	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTEN—head and neck cancer	7.3e-05	0.000155	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAPK3—head and neck cancer	7.27e-05	0.000155	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	7.21e-05	0.000153	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTGS2—head and neck cancer	7.09e-05	0.000151	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—head and neck cancer	6.97e-05	0.000148	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAPK1—head and neck cancer	6.92e-05	0.000147	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EGFR—head and neck cancer	6.92e-05	0.000147	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TYMS—head and neck cancer	6.83e-05	0.000145	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTM1—head and neck cancer	6.75e-05	0.000143	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HRAS—head and neck cancer	6.67e-05	0.000142	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AKT1—head and neck cancer	6.55e-05	0.000139	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPX1—head and neck cancer	6.46e-05	0.000137	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—AKT1—head and neck cancer	6.45e-05	0.000137	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP1A1—head and neck cancer	6.4e-05	0.000136	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTEN—head and neck cancer	6.18e-05	0.000131	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	6e-05	0.000128	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—AKT1—head and neck cancer	5.89e-05	0.000125	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—head and neck cancer	5.81e-05	0.000123	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HRAS—head and neck cancer	5.56e-05	0.000118	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CA—head and neck cancer	5.15e-05	0.000109	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—AKT1—head and neck cancer	4.91e-05	0.000104	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CA—head and neck cancer	4.36e-05	9.26e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AKT1—head and neck cancer	4.21e-05	8.94e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.8e-05	8.08e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AKT1—head and neck cancer	3.56e-05	7.57e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTEN—head and neck cancer	3.32e-05	7.05e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.34e-05	4.97e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AKT1—head and neck cancer	1.91e-05	4.06e-05	CbGpPWpGaD
